Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma.

Henk, Henry J

Persistency with zoledronic acid is associated with clinical benefit in patients with multiple myeloma. [electronic resource] - American journal of hematology May 2012 - 490-5 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1096-8652

10.1002/ajh.23164 doi


Administration, Oral
Aged
Bone Density Conservation Agents--administration & dosage
Databases, Factual
Diphosphonates--administration & dosage
Drug Utilization
Female
Fractures, Spontaneous--epidemiology
Humans
Imidazoles--administration & dosage
Incidence
Infusions, Intravenous
International Classification of Diseases
Male
Medication Adherence
Middle Aged
Multiple Myeloma--complications
Osteolysis--epidemiology
Retrospective Studies
Treatment Outcome
United States--epidemiology
Zoledronic Acid